Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 16 of 16 for “"Milrinone"”.
-
Development and testing of a simulated closed loop drug delivery system for CHF patients under milrinone administration
… The focus of this study is on the control of milrinone inflision to maintain cardiac output at desired setpoint range for patients suffering from congestive heart failure (CHF). The simulated CLDD system is written in VisSim dynamic simulation language for an IBM-compatible PC. Milrinone …
-
Nimodipin versus Milrinon bei der endovaskulären zerebralen Vasospasmolyse - gleichwertiger oder komplementärer Einsatz?
… it is believed not to affect large vessel CVS. Milrinone has emerged as a promising option. Our retrospective study focused on the effectiveness of the intra-arterial application of both drugs in monotherapy and combined therapy. Methods: We searched for patients with aneurysmal SAH, …
-
Cambios en la microcirculación asociados al uso de infusiones de Milrinona en niños con choque séptico
… the endothelial glycocalyx associated with using milrinone in children with sepsis. Sublingual videomicroscopy was used to assess capillary density (DC4-6 microns and DC7-25 microns), microvascular flow index, and perfused blood region (perfusion boundary region (PBR), inverse parameter of …
-
Η επίδραση της μιλρινόνης στον μεταβολισμό μετά από εξωσωματική κυκλοφορία
AIM: We examined the effects of milrinone, on tissue metabolism perioperatively in cardiac surgery patients using cardiopulmonary bypass (CPB), in comparison to adrenaline and placebo. These effects were measured indirectly by measuring serum lactate, base excess and glucose levels at standard …
-
Η αντιμετώπιση της πνευμονικής υπέρτασης σε καρδιοχειρουργικούς ασθενείς υψηλού κινδύνου με τη χρήση εισπνευστικών και ενδοφλέβιων παραγόντων
… afterload and enhance its contractility. Milrinone and levosimendan are two pharmacological agents used in the management of PH and right heart failure. Milrinone, a phosphodiesterase type 3 inhibitor, has inotropic and vasodilatory effects. However, intravenous administration of milrinone …
-
Αξιολόγηση νεώτερων ινότροπων φαρμάκων στην αιμοδυναμική ανταπόκριση της οξείας καρδιακής ανεπάρκειας
… the clinical outcome between levosimendan and milrinone in decompensated chronic heart failure using a prolonged infusion pattern without a loading dose. Method: 50 patients admitted to emergencies for acute or decompensated heart failure, participated in the study. They divided in two …
-
Acute haemodynamic effects of three cardioactive agents: metoprolol, sotalol and milrinone : influence of myocardial content and systolic interval / by Rebecca Helen Ritchie.
Utilizing a paired transcoronary sampling technique, serial determination of myocardial drug content was determined following intravenous bolus injection in patients undergoing diagnostic cardiac catheterization for the investigation of chest pain. There was significant modulation of haemodynamic …
-
Inhaled vasodilators as a new treatment strategy in pulmonary hypertension with left heart disease
… in vivo after inhalation of the vasodilators milrinone, iloprost or NO at rest, and inhaled iloprost at increased lung perfusion after administration of the β1-agonist dobutamine. Alveolar fluid reabsorption and endothelial NO production in CHF were quantified in the isolated perfused rat lung …
-
Modelling Renal Function in Drug Pharmacokinetics
… and population PK analyses of cefazolin and milrinone, two renally eliminated drugs. Cardiopulmonary bypass (CPB) is associated with large physiological disturbances and can impact drug PK through changes in renal function, haemodilution, haemofiltration and drug adsorption to the CPB device. …
-
Μελέτη των υπερηχορρεομετρικών (doppler) δεικτών σε ασθενείς με καρδιακή ανεπάρκεια που αντιμετωπίζονται με νεώτερους φαρμακολογικούς παράγοντες ή βηματοδότηση
… administered inotropic agents, levosimendan and milrinone in acute heart failure vs biventricular implantation measured by hemodynamic parameters and simple markers of cardiac function. The unique aspect of this study is the comparison between the two agents in humans while it has been an effort …
-
Descripción de experiencia en manejo perioperatorio en procedimientos no cardiacos en pacientes con Cirugía de Fontan en la Fundación CardioInfantil-IC entre enero de 2016 a junio de 2019
… dysfunction that required inotropic support with Milrinone and vasopressor support in ICU in the postoperative period of non-cardiac procedure.
-
Assessment of Left Ventricular Contractility and Loading Conditions Under Continuous-flow Left Ventricular Assist Device Support
… pharmacodynamic effects of intravenous Milrinone. Finally, I utilise this pressure-volume derivation in order to assess the haemodynamic effects of exercise, revealing increased left ventricular contraction that is likely driven by increased preload, and profoundly diminished unloading …
-
Relaxin: a new cardiovascular hormone in humans? Comparative potency and mechanisms of action
… of the cAMP second messenger system, with milrinone, (a cAMP phosphodiesterase inhibitor) (n=6) is also important as relaxin’s vasodilatory action was enhanced. Manipulation of cyclic GMP second messenger system is also important. ODQ, (a guanylate cyclase inhibitor) (n=10) reduced …
-
Fabrication of perfusion microbioreactor for culturing engineered heart tissue with electrical stimulation
… drugs. Five drugs, including Ouabain, Bay k8644, Milrinone, Amlodipine and Ryanodine, all clinically approved to treat various cardiovascular diseases, were used for the evaluation tests. The tested drugs at different dosages were added into the culture medium and the latter was perfused into the …
-
Targets of cyclic GMP in Blood Platelets: Photolabelling, mutagenesis and pharmacological analysis of the cyclic GMP-inhibited phosphodiesterase
… = 13 ± 2 nM), lixazinone (IC₅₀ = 22 ± 4 nM), milrinone (IC₅₀ = 56 ± 12 nM), cilostamide (IC₅₀ = 70 ± 9 nM), siguazodan (IC₅₀ 117 ± 29 nM) and 3-isobutyl 1-methylxanthine (IBMX) (IC₅₀ = 3950 ± 22 nM). The effects of these phosphodiesterase inhibitors on iloproststimulated cAMP accumulation in …